05.02.2022 - By Pocket Psychiatry: A Carlat Podcast
Do anticholinergic medications increase the risk of long-term cognitive decline and dementia? In this podcast, we will review the latest research examining the relationship between anticholinergic medication use and cognitive decline.CME: Take the Podcast CME Post-Test here (www.thecarlatreport.com/podcastcme). Not subscribed to earn CME credit for listening? Click here (https://www.thecarlatreport.com/product/carlat-psychiatry-podcast-cme-subscription/)to start earning CME credit for podcast episodes!Published On: 05/02/2022Duration: 15 minutes, 58 secondsReferenced Article: “Anticholinergic Drugs and Risk of Cognitive Impairment and Dementia (https://www.thecarlatreport.com/the-carlat-hospital-psychiatry-report/anticholinergic-drugs-and-risk-of-cognitive-impairment-and-dementia/),” The Carlat Hospital Psychiatry Report, October/November/December 2021Victoria Hendrick, MD, Zachary N. Davis, BS, and Shelly Gray, PharmD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.